NCT02683486

Brief Summary

The aim of this study is to assess whether an auto-titrating oxygen system can maintain constant oxygen saturations (SpO2) in patients who are on long-term oxygen therapy (LTOT) during activities of daily living. Currently LTOT is provided at a constant fixed-flow rate e.g. 2 litres per minute all the time after appropriate assessment. The flow rate is not changed during usual household activities but is increased for walking. A number of studies have investigated the SpO2 of patients on LTOT during the daytime in patients' homes. The results have shown that patients' SpO2 decreases intermittently whilst they are doing activities of daily living such as watching television, putting away the shopping, having a shower or bath and dressing and undressing. This is a problem as it can lead to breathlessness, increased stress on the heart and affect brain function. In order to correct the drop in SpO2 that patients experience during everyday activities, the investigators have developed an oxygen system, which can automatically change the amount of oxygen delivered depending on a patients' oxygen saturations - an auto-titrating oxygen system. In this study, patients on LTOT will be asked to simulate a series of activities of daily living twice: once whilst on their usual fixed-flow oxygen therapy and once on the auto-titrating oxygen system. The activities will be carried out in a hospital setting. During the activities, SpO2 will be recorded continuously. The main outcome of interest from the study will be the SpO2 throughout the study on fixed-flow oxygen and the auto-titrating oxygen system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

January 26, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 17, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2017

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

January 26, 2016

Last Update Submit

November 23, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The percentage of time spent with SpO2 <90% during the activities of daily living - 55 minutes

    Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)

Secondary Outcomes (4)

  • Mean SpO2 during the activities of daily living - 55 minutes

    Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)

  • Mean Heart rate during the activities of daily living - 55 minutes

    Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)

  • Borg score for breathlessness and fatigue at the end of activities of daily living (55 minutes)

    At the end of activities of daily living (55 minutes)

  • Total volume of oxygen delivered during simulated activities of daily living during the activities of daily living (55 minutes)

    Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)

Study Arms (2)

Activities of daily living on iO2t

EXPERIMENTAL

Patients will complete simulated activities of daily living on intelligent oxygen therapy (an auto-titrating oxygen system)

Device: Intelligent oxygen therapy (an auto-titrating oxygen system)

Activities of daily living on LTOT

ACTIVE COMPARATOR

Patients will complete activities of daily living on their usual long-term oxygen therapy.

Device: Long-term oxygen therapy

Interventions

This device is an auto-titrating oxygen system. The system is programmed to maintain a specific target SpO2 by automatically adjusting the oxygen flow rate. The system can deliver flow rates of 0-5 litres/minute.

Activities of daily living on iO2t

This is the patients usual long-term oxygen therapy

Activities of daily living on LTOT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • Currently on or eligible for LTOT for respiratory failure

You may not qualify if:

  • LTOT flow rate ≥4 litres per minute
  • Exacerbation of underlying lung disease in the past 4 weeks
  • Inability to understand English
  • Significant co-morbidities
  • Patients who lack capacity to consent
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Brompton and Harefield NHS Trust

London, SW3 6NP, United Kingdom

Location

Related Publications (1)

  • Mohammad Moghal, Rishi Goburdhun, Mary Morrell, Robert Dickinson, Anita Simonds A Novel Smartphone Based Auto-Titrating Oxygen System Reduces Intermittent Hypoxia During Activities of Daily Living in Patients on Long-Term Oxygen Therapy. American Journal of Respiratory and Critical Care Medicine 2017;195:A7709

    RESULT

Related Links

MeSH Terms

Conditions

HypoxiaPulmonary Disease, Chronic ObstructiveHyperoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic Processes

Study Officials

  • Anita Simonds, FRCP

    Royal Brompton & Harefield NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2016

First Posted

February 17, 2016

Study Start

January 1, 2016

Primary Completion

January 1, 2017

Study Completion

January 15, 2017

Last Updated

November 29, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations